SCHEDULE: Hellman & Friedman Funds Increase Medline Stake

Several Hellman & Friedman affiliated entities have amended their Schedule 13G filing to report an aggregate beneficial ownership of 16.0% of Medline Inc.'s Class A common stock as of June 30, 2026.

Summary

• This filing is an amendment to a Schedule 13G, indicating a change in beneficial ownership of Medline Inc. Class A common stock.
• As of June 30, 2026, several reporting persons affiliated with Hellman & Friedman may be deemed to beneficially own an aggregate of 153,327,675 shares of Class A Common Stock.
• This represents 16.0% of the Class A Common Stock outstanding, calculated based on 877,351,218 shares outstanding plus 82,453,349 shares issuable upon exchange of common units.
• The reporting persons include various L.P. and L.L.C. entities such as Hellman & Friedman Capital Partners X (Parallel), L.P., HFCP X (Parallel - A), L.P., Mend Partners II, L.P., Mend Investment Holdings I, L.P., Hellman & Friedman Investors X, L.P., Mend Partners GP, LLC, Mend Investment Holdings GP, LLC, Hellman & Friedman Capital Partners X, L.P., and H&F Corporate Investors X, Ltd.
• Specific holdings include 61,054,619 shares by HFCP X Parallel, 6,377,698 by HFCP X Parallel-A, 3,422,699 by Mend Partners II, and 82,472,659 by Mend Investment I (including shares issuable upon exchange).
• The filing details the relationships between the reporting entities, with general partners and managing members holding voting and investment discretion over the shares.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this filing as having a neutral to slightly negative sentiment due to its nature as a routine Schedule 13G amendment reporting increased ownership, without providing new operational or financial performance data.

Positives

• Increased beneficial ownership by significant investment entities suggests confidence in Medline Inc.'s long-term prospects.
• The reporting entities collectively hold a substantial 16.0% stake, indicating significant influence and investment commitment.

Negatives

• The filing does not provide any new operational or financial performance data for Medline Inc., making it difficult to assess the company's current health.
• The increase in ownership is reported as of June 30, 2026, and may not reflect the most current ownership structure or market sentiment.

Risks

• The filing itself does not introduce new risks but reflects the investment risk associated with holding a significant stake in a company.
• Potential for future changes in ownership or strategic decisions by these large shareholders could impact the company's direction.

Future Outlook

The filing does not contain forward-looking statements or guidance from Medline Inc. It only reports on ownership changes by the filing entities.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for institutional investors accumulating significant stakes. The increased ownership by Hellman & Friedman affiliated funds in Medline Inc. aligns with broader trends of private equity and investment firms actively managing and increasing positions in publicly traded companies, particularly those with stable business models.

Stakeholder Impact

• Shareholders: Potential for increased market activity or strategic shifts due to significant ownership by large investment firms.
• Creditors: Indirect impact through potential changes in company strategy or financial management influenced by major shareholders.
• Management: May face increased scrutiny or influence from the reporting entities regarding corporate strategy and governance.

Next Steps

• Continued monitoring of Medline Inc.'s performance and any further ownership filings by these entities.

Key Dates

Keywords

Medline Inc., Schedule 13G, Beneficial Ownership, Hellman & Friedman, Investment Holdings, Class A Common Stock, Amendment